University Of California, San Francisco

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Dexmedetomidine in Seizure Patients

Phase 1

Completed

Conditions: Seizure Disorders

First Posted Date: 2010-05-05

Last Posted Date: 2013-08-09

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 16

Registration Number: NCT01116700

Locations: 🇺🇸
University of California San Francisco, San Francisco, California, United States

Safety Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Tumors of the Brain

Phase 2

Terminated

Conditions: Glioma

Interventions: Drug: 5-Aminolevuline Acid (ALA)

First Posted Date: 2010-05-05

Last Posted Date: 2019-05-29

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 199

Registration Number: NCT01116661

Locations: 🇺🇸
UCSF Department of Neurosurgery, San Francisco, California, United States

Global and Regional Myocardial Strain and Power Output In Patients With Single Ventricles Using Novel MRI Techniques

Terminated

Conditions: Tricuspid Atresia
Double Inlet Left Ventricle
Fontan Procedure
Hypoplastic Left Heart Syndrome

First Posted Date: 2010-04-21

Last Posted Date: 2020-01-21

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 13

Registration Number: NCT01107990

Locations: 🇺🇸
University of California, San-Francisco, San Francisco, California, United States

Factors Association With Poor Physical Function in Older Adults With Schizophrenia

Completed

Conditions: Schizoaffective Disorder
Schizophrenia

First Posted Date: 2010-03-25

Last Posted Date: 2015-05-27

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 46

Registration Number: NCT01092598

Locations: 🇺🇸
UCSF, San Francisco, California, United States

Mesalamine to Reduce T Cell Activation in HIV Infection

Phase 4

Completed

Conditions: HIV Infections
Sexually Transmitted Diseases
Immune System Diseases
Lentivirus Infections
Acquired Immunodeficiency Syndrome

Interventions: Drug: Mesalamine (5-aminosalicylic acid, Apriso)
Drug: Placebo

First Posted Date: 2010-03-19

Last Posted Date: 2014-08-13

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 33

Registration Number: NCT01090102

Locations: 🇺🇸
University of California, San Francisco-San Francisco General Hospital, San Francisco, California, United States

Pharmacokinetic Study in Patients With Chronic Kidney Disease and Healthy Volunteers

Phase 1

Completed

Conditions: Kidney Disease

Interventions: Drug: Propranolol
Drug: Losartan
Drug: Eprosartan

First Posted Date: 2010-03-16

Last Posted Date: 2013-05-30

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 24

Registration Number: NCT01087749

Locations: 🇺🇸
Clinical Reserach Center, UCSF, San Francisco,, California, United States

Topiramate Treatment of Alcohol Use Disorders in Veterans With Post Traumatic Stress Disorder (PTSD): A Pilot Controlled Trial of Augmentation Therapy

Phase 4

Completed

Conditions: Alcoholism
Alcohol Abuse
PTSD

Interventions: Other: Placebo administration
Drug: Topiramate

First Posted Date: 2010-03-16

Last Posted Date: 2014-06-03

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 30

Registration Number: NCT01087736

Locations: 🇺🇸
San Francisco VA Medical Center, San Francisco, California, United States

Text Messaging and Cognitive Behavioral Therapy for Depression

Not Applicable

Completed

Conditions: Depression

Interventions: Behavioral: Group CBT for Depression with MoodText
Behavioral: Group CBT for Depression

First Posted Date: 2010-03-10

Last Posted Date: 2019-08-12

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 85

Registration Number: NCT01083628

Locations: 🇺🇸
San Francisco General Hospital, San Francisco, California, United States

Improving Sleep and Quality of Life in Adults With HIV Disease

Not Applicable

Completed

Conditions: Insomnia

Interventions: Behavioral: Music Therapy
Behavioral: Yoga

First Posted Date: 2010-02-23

Last Posted Date: 2010-06-23

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 20

Registration Number: NCT01073423

Chitinases and Transforming Growth Factor Beta (TGFB) in Human Asthma

Completed

Conditions: Asthma

First Posted Date: 2010-02-23

Last Posted Date: 2022-02-01

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 23

Registration Number: NCT01073410

Locations: 🇺🇸
UCSF Airway Clinical Research Center, San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy